Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 18, 2022

SELL
$1.42 - $3.15 $35,500 - $78,750
-25,000 Closed
0 $0
Q1 2022

Apr 12, 2022

SELL
$2.65 - $5.08 $92,750 - $177,800
-35,000 Reduced 58.33%
25,000 $71,000
Q4 2021

Feb 07, 2022

BUY
$4.73 - $7.9 $283,800 - $474,000
60,000 New
60,000 $292,000

Others Institutions Holding SURF

About Surface Oncology, Inc.


  • Ticker SURF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,034,000
  • Description
  • Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...
More about SURF
Track This Portfolio

Track Connective Portfolio Management, LLC Portfolio

Follow Connective Portfolio Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connective Portfolio Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Connective Portfolio Management, LLC with notifications on news.